Fast-paced Momentum Stock Exagen (XGN) Is Still Trading at a Bargain

Group 1: Momentum Investing Overview - Momentum investing deviates from the traditional strategy of "buying low and selling high," focusing instead on "buying high and selling higher" to achieve quicker profits [1] - Fast-moving trending stocks can be challenging to enter at the right time, as they may lose momentum if future growth does not justify their inflated valuations [2] Group 2: Investment Strategy - A safer investment approach involves targeting bargain stocks that exhibit recent price momentum, utilizing tools like the Zacks Momentum Style Score to identify promising candidates [3] - Exagen Inc. (XGN) is highlighted as a strong candidate, with a notable price increase of 31.7% over the past four weeks, indicating growing investor interest [4] Group 3: Performance Metrics - XGN has demonstrated significant momentum, gaining 28.3% over the past 12 weeks, with a beta of 1.28, suggesting it moves 28% more than the market [5] - XGN holds a Momentum Score of A, indicating a favorable entry point for investors looking to capitalize on its momentum [6] Group 4: Earnings and Valuation - An upward trend in earnings estimate revisions has contributed to XGN's Zacks Rank 2 (Buy), as increased analyst interest typically attracts more investors [7] - XGN is trading at a Price-to-Sales ratio of 0.75, suggesting it is undervalued, as investors pay only 75 cents for each dollar of sales [7] Group 5: Additional Opportunities - Besides XGN, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting further investment opportunities [8] - The Zacks Premium Screens offer over 45 different strategies tailored to help investors identify winning stock picks [9]